Integer (NYSE:ITGR) Shares Gap Down to $123.27

Shares of Integer Holdings Co. (NYSE:ITGR) gapped down prior to trading on Thursday . The stock had previously closed at $123.27, but opened at $114.00. Integer shares last traded at $112.86, with a volume of 342,010 shares changing hands.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on ITGR shares. KeyCorp raised their price target on Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and raised their price target for the company from $105.00 to $135.00 in a research report on Monday, April 15th. CL King started coverage on Integer in a research report on Thursday, March 14th. They set a “buy” rating and a $137.00 price objective for the company. Finally, Benchmark reiterated a “buy” rating and set a $130.00 price objective on shares of Integer in a research report on Friday. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $120.50.

Integer Trading Down 1.4 %

The stock has a market cap of $3.67 billion, a PE ratio of 40.74, a PEG ratio of 1.71 and a beta of 1.10. The business has a 50-day moving average of $113.11 and a 200 day moving average of $99.78. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.71 and a current ratio of 2.80.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.02. Integer had a return on equity of 10.80% and a net margin of 5.68%. The firm had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. During the same period last year, the company earned $0.87 EPS. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. Equities research analysts predict that Integer Holdings Co. will post 5.31 EPS for the current fiscal year.

Hedge Funds Weigh In On Integer

Several hedge funds and other institutional investors have recently modified their holdings of the company. Wesbanco Bank Inc. acquired a new position in shares of Integer in the 1st quarter valued at about $1,904,000. Raymond James & Associates lifted its stake in shares of Integer by 1.4% in the 1st quarter. Raymond James & Associates now owns 49,648 shares of the medical equipment provider’s stock valued at $5,793,000 after purchasing an additional 702 shares in the last quarter. Norden Group LLC acquired a new position in shares of Integer in the 1st quarter valued at about $526,000. Azzad Asset Management Inc. ADV lifted its stake in shares of Integer by 7.9% in the 1st quarter. Azzad Asset Management Inc. ADV now owns 7,772 shares of the medical equipment provider’s stock valued at $907,000 after purchasing an additional 566 shares in the last quarter. Finally, Tributary Capital Management LLC lifted its stake in shares of Integer by 1.2% in the 1st quarter. Tributary Capital Management LLC now owns 285,677 shares of the medical equipment provider’s stock valued at $33,333,000 after purchasing an additional 3,513 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.